The cyclin-dependent kinase inhibitor 2A (CDKN2A) gene inactivation is significantly more common in SqCLC than in other non–small cell lung cancer (NSCLC) subtypes [3]. Here, CDKN2A is linked to non-small cell lung carcinoma.